Dulaglutide Biosimilar (Luye Pharma)

度拉糖肽生物类似药 (绿叶制药)

Report date: 2025/08/08 16:50:02

Base Information

Drug NameDulaglutide Biosimilar (Luye Pharma)
Drug Alias NameTrulicity biosimilar (Luye Pharma)博优平LY-05008BA-5101
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryMainland China
Original Approved Date2025/08/05
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Boan Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Boan Biotechnology Co Ltd
Inactive CompaniesLuye Pharma Group Ltd
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A